EY’s Pointellis Platform Uses Microsoft Azure to Deliver Custom Cancer Treatment

EY's Pointellis Platform Uses Microsoft Azure to Deliver Custom Cancer Treatment

EY Health Sciences and Wellness is releasing a digital ecosystem that will make it easier for doctors to deliver more personalized treatment to cancer patients. Dubbed Pointellis, the new platform tracks the medical supply chain from a patient’s first biopsy all the way through to treatment scheduling and payment.

Pointellis is built with Microsoft’s open source Azure technology. The platform will facilitate the secure transfer of information between hospitals, laboratories, and other care centers to make sure that everyone has the most up-to-date patient records when making treatment decisions.  

“Individualized therapies can considerably improve patient outcomes and alleviate the burden of cancer and mutation-based diseases,” said EY Wellness Industry Leader Pamela Spence. “EY teams are bringing parties together that have specific skills relevant to solving some of the greatest supply chain and operational complexities.”

According to EY, Pointellis will make make patients more engaged with their own care, and allow doctors to come up with a treatment schedule that addresses every patient’s unique individual needs. It also demonstrates the versatility of the Azure platform, which has been leveraged for secure identity verification by companies like Entrust Datacard and Veridium.

Microsoft recently brought support for FIDO2 and WebAuthn password-free authentication standards to the Azure Active Directory, which has been leveraged for secure identity verification.